FRMO Corporation (FRMO)

Sage Therapeutics Income Statement

Financials in millions USD. Fiscal year is June - May.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 28, 2025	May 31, 2024	May 31, 2023	May 31, 2022	May 31, 2021	May 31, 2020
Operating Revenue	4.56	2.71	3.22	4.68	3.72	2.26
Other Revenue	432.86	135.71	-36.37	9.2	146.85	-24.41
Revenue	437.42	138.43	-33.15	13.87	150.57	-22.14
Revenue Growth (YoY)	1742.73%	-	-	-90.79%	-	-
Gross Profit	437.42	138.43	-33.15	13.87	150.57	-22.14
Selling, General & Admin	1.41	1.31	1.5	1.08	1.12	1.22
Operating Expenses	1.6	1.56	1.84	1.38	1.35	1.34
Operating Income	435.83	136.87	-34.98	12.49	149.22	-23.48
Pretax Income	435.83	136.87	-34.98	12.49	149.22	-23.48
Income Tax Expense	43.14	18.42	-3.22	-0.77	19.89	-0.15
Earnings From Continuing Operations	392.69	118.45	-31.76	13.27	129.33	-23.33
Minority Interest in Earnings	-227.44	-45.89	19.16	-10.32	-69.17	8.76
Net Income	165.24	72.56	-12.6	2.95	60.16	-14.56
Net Income to Common	165.24	72.56	-12.6	2.95	60.16	-14.56
Net Income Growth	451.36%	-	-	-95.10%	-	-
Shares Outstanding (Basic)	44	44	44	44	44	44
Shares Outstanding (Diluted)	44	44	44	44	44	44
Shares Change (YoY)	0.01%	0.01%	-0.03%	-0.01%	0.01%	0.04%
EPS (Basic)	3.75	1.65	-0.29	0.07	1.37	-0.33
EPS (Diluted)	3.75	1.65	-0.29	0.07	1.37	-0.33
EPS Growth	451.42%	-	-	-95.10%	-	-
Free Cash Flow	8.06	3.59	5.01	0.8	-0.26	0.16
Free Cash Flow Per Share	0.18	0.08	0.11	0.02	-0.01	0.00
Gross Margin	100.00%	100.00%	-	100.00%	100.00%	-
Operating Margin	99.63%	98.88%	-	90.05%	99.10%	-
Profit Margin	37.78%	52.42%	-	21.23%	39.95%	-
Free Cash Flow Margin	1.84%	2.59%	-	5.79%	-0.18%	-
EBITDA	436.01	137.12	-34.64	12.79	149.45	-23.36
EBITDA Margin	99.68%	99.06%	-	92.20%	99.26%	-
D&A For EBITDA	0.18	0.25	0.34	0.3	0.23	0.12
EBIT	435.83	136.87	-34.98	12.49	149.22	-23.48
EBIT Margin	99.63%	98.88%	-	90.05%	99.10%	-
Effective Tax Rate	9.90%	13.46%	-	-	13.33%	-
Revenue as Reported	437.42	138.43	-33.15	13.87	150.57	-22.14

Updated Jan 15, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.